Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc. > CAN ANYONE TELL ME HOW YOU FIND THE MOST VIEWED STOCKS ON SO
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(731)
•••
Comment by O12009on Jan 02, 2025 7:15pm
178 Views
Post# 36385417

RE:RE:CAN ANYONE TELL ME HOW YOU FIND THE MOST VIEWED STOCKS ON SO

RE:RE:CAN ANYONE TELL ME HOW YOU FIND THE MOST VIEWED STOCKS ON SO
It is an email that they send each day about one hour after the markets close
 
Stockhouse.com
 
Investor Alert
 
Canadian and U.S. stocks begin 2025 with a mixed bag

THURSDAY, JAN 2, 2025

Canada’s TSX index ended with a solid gain on the first trading day of 2025 thanks to optimism in healthcare (2.2%), energy (1.61%) and base metal (1.13%) stocks. Top gainers include i-80 Gold (24.63%) and Denison Mines (14.17%), with Power Corporation of Canada giving back 1.69%.
 

TODAY IN THE MARKETS |
Name Price Change
 
TSX 24,898.03 +170.09 TSX
 
TSXV 617.35 +19.51 TSXV
 
CSE 139.63 +4.55 TSXV
 
DJIA 42,392.27 -151.95 DJIA
 
NASDAQ 19,280.79 -29.999 NASDAQ
 
S&P 500 5,868.55 -13.08 S&P 500
 

TOP BULLBOARDS |
Company Ticker Views
Quantum eMotion Corp V.QNC 7197
PyroGenesis Inc T.PYR 4411
Theralase Technologies V.TLT 3068
Baytex Energy Corp T.BTE 2654
Bombardier Inc. T.BBD.A 1822
Uranium Energy Corp UEC 1760
BCE Inc T.BCE 1601
Laurion Mineral Exploration Inc. V.LME 1534
American Creek Resources Ltd V.AMK 1457
Tudor Gold Corp V.TUD 1323
View The Watchlist
 

NEW CEO INTERVIEWS |

Medicus Pharma Ltd. Announces Minor Use Designation from the FDA for Doxorubicin-Containing Microneedle Array Patch
 

TOP STORIES |

Eric Sprott throws weight behind Manganese X Energy
Manganese X Energy (TSXV:MN) will undertake a $2.1 million non-brokered private placement, including a $2 million commitment from Eric Sprott, one of Canada’s most storied and successful mining investors.

Due diligence checklist for researching small-cap stocks
Investing in small-cap stocks can be highly rewarding but also comes with significant risks. Conducting thorough due diligence is crucial to making informed investment decisions.

This Bitcoin mining stock is ramping up operations in 2025
HIVE Digital Technologies (TSXV:HIVE), a Bitcoin mining and AI infrastructure stock, recently reached an operational hashrate of 6 exahashes per second (EH/s), representing 47 per cent year-over-year growth.
 

WORD ON WALLSTREET | 

U.S. stocks started the year with a loss amid falling investor confidence in the dollar’s continued strength and what upcoming Q4 earnings have in store. Top gainers include N2OFF (331.45%) and Vistra (8.55%), with Tesla shares giving back over 6%.
 

TODAY IN THE MARKETS | 

The Canadian dollar traded for 69.36 cents U.S. compared to 69.50 cents U.S. on Tuesday.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities